Gland Pharma Limited (BOM:543245)
India · Delayed Price · Currency is INR 1,782.15
-12.25 (-0.68%)
At close: Apr 21, 2026
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 293.43 billion as of April 21, 2026. Its market cap has increased by 10.98% in one year.
Market Cap
293.43B
Enterprise Value
264.43B
Revenue
61.13B
Ranking
n/a
PE Ratio
34.64
Stock Price
1,782.15
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 293.43B, a decrease of -1.24%. That is a compound annual growth rate of -0.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 293.43B | 3.43% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 1.03T |
| Abbott India | 543.53B |
| GlaxoSmithKline Pharmaceuticals | 412.01B |
| J. B. Chemicals & Pharmaceuticals | 319.99B |
| AstraZeneca Pharma India | 213.00B |
| Granules India | 164.48B |
| Rubicon Research | 152.81B |
| Jubilant Pharmova | 143.25B |